Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

CoraDoc vs NewSelf

By GLP-1 ScorecardUpdated

CoraDoc
Site position #50

Lower grade

NewSelf
Site position #39

Higher grade

Score comparison

NewSelf has the higher recorded score — 79.8/100 to 76.8/100.

NewSelf grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Round-$100 semaglutide, $144 tirzepatide, verified and available in all 50 states.

We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.

Factor by factor

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.

Cost valueCoraDoc +3
96
93
Dose & formulationNewSelf +8
72
80
Clinical oversightCoraDoc +24
79
55
Labs & monitoringNewSelf +29
53
82
FulfillmentNewSelf +11
76
87
Contract termsNewSelf +16
69
85
CoraDoc · top barNewSelf · bottom bar

The numbers

Swipe or scroll to compare both providers.

MetricCoraDocNewSelf
WeighScore76.8/10079.8/100
GradeCC+
Site position#50#39
Semaglutide$99/mo (all doses, compounded)$100/mo
Tirzepatide$165/mo (all doses, compounded)$144/mo
CoverageCoverage not publishedAll 50 states
Brand-name accessNot confirmedNot confirmed
Oral / sublingualNot confirmedNot confirmed
CoraDoc

Site position #50 · C

Strengths

  • Low flat pricing — compounded semaglutide from $99/mo, tirzepatide from $165/mo, no subscription
  • Triple Free Promise: free provider visit, free 2-day shipping, and free supplies included
  • Available in all 50 states; HSA/FSA plus Afterpay/Klarna/Affirm; full refund if not approved
  • Full legal suite published (Terms, Privacy, Refund Policy); board-certified providers

What to consider

  • Lowest $99 price is the longest-commitment tier (programs range about $99-$199/mo)
  • Compounding pharmacy partner not named
  • 'LegitScript Certified' is stated prominently but was not independently verified here
  • Operating legal entity not clearly named on the site
NewSelf

Site position #39 · C+

FDAWarning letter issued to NewSelf Limited dba NewSelf in February 2026. See the FDA warning-letter database.

Strengths

  • $100 sema / $144 tirz
  • All 50 states, LegitScript-verified
  • Both molecules

What to consider

  • Injection-only
  • Labs/monitoring detail sparse
  • Limited brand history

Featured provider

CoreAge Rx

CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.

Commercial relationships affect this placement. The score comparison above is separate.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard